Edition:
India

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.89USD
22 Nov 2017
Change (% chg)

$0.01 (+1.11%)
Prev Close
$0.88
Open
$0.89
Day's High
$0.93
Day's Low
$0.89
Volume
138,931
Avg. Vol
133,617
52-wk High
$3.10
52-wk Low
$0.79

Select another date:

Wed, Nov 8 2017

BRIEF-Regulus Therapeutics Q3 loss per share $0.18

* Regulus reports third quarter 2017 financial results and recent events

BRIEF-Regulus Q3 loss per share $0.18

* Regulus reports third quarter 2017 financial results and recent events

BRIEF-Growth Equity Opportunities reports 11.3 pct stake in Regulus Therapeutics

* Growth Equity Opportunities V reports 11.3 percent stake in Regulus Therapeutics Inc as of July 24 - SEC filing Source text: (http://bit.ly/2u4yxoS) Further company coverage:

BRIEF-Regulus Therapeutics Q2 loss per share $0.41

* Regulus reports second quarter 2017 financial results and recent events

BRIEF-Broadfin Capital reports 5.65 pct passive stake in Regulus Therapeutics - ‍​SEC filing

* Broadfin Capital LLC reports 5.65 percent passive stake in Regulus Therapeutics Inc as of July 20, 2017 - ‍​SEC filing Source text: (http://bit.ly/2vSFqWv) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

BRIEF-Aptuit announces strategic provider agreement with Regulus Therapeutics

* Aptuit announces strategic provider agreement with Regulus Therapeutics Source text for Eikon: Further company coverage:

BRIEF-EcoR1 Capital reports 9.6 pct passive stake in Regulus Therapeutics

* EcoR1 Capital LLLC reports a 9.6 percent passive stake in Regulus Therapeutics Inc as of May 17 - SEC filing Source text for Eikon: (http://bit.ly/2r8sCMk) Further company coverage:

Select another date: